Dana Investment Advisors Inc. Has $8.11 Million Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Dana Investment Advisors Inc. lowered its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 1.3% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 117,812 shares of the company’s stock after selling 1,575 shares during the quarter. Dana Investment Advisors Inc. owned 0.24% of Prestige Consumer Healthcare worth $8,111,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of PBH. Vanguard Group Inc. raised its position in shares of Prestige Consumer Healthcare by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 5,756,138 shares of the company’s stock worth $352,391,000 after purchasing an additional 63,375 shares during the period. Ariel Investments LLC raised its holdings in Prestige Consumer Healthcare by 10.7% during the 2nd quarter. Ariel Investments LLC now owns 2,835,203 shares of the company’s stock worth $195,204,000 after buying an additional 274,212 shares during the period. Victory Capital Management Inc. lifted its stake in Prestige Consumer Healthcare by 9.0% in the second quarter. Victory Capital Management Inc. now owns 2,074,460 shares of the company’s stock valued at $142,827,000 after buying an additional 171,357 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its stake in Prestige Consumer Healthcare by 26.0% in the second quarter. Allspring Global Investments Holdings LLC now owns 1,320,125 shares of the company’s stock valued at $90,891,000 after buying an additional 272,773 shares in the last quarter. Finally, Congress Asset Management Co. MA boosted its holdings in shares of Prestige Consumer Healthcare by 12.5% in the first quarter. Congress Asset Management Co. MA now owns 764,013 shares of the company’s stock valued at $55,437,000 after buying an additional 84,757 shares during the period. Institutional investors own 99.95% of the company’s stock.

Prestige Consumer Healthcare Stock Up 1.1 %

Shares of PBH stock opened at $72.08 on Tuesday. The firm’s fifty day moving average price is $71.22 and its two-hundred day moving average price is $69.54. The company has a current ratio of 3.23, a quick ratio of 1.90 and a debt-to-equity ratio of 0.65. Prestige Consumer Healthcare Inc. has a 1 year low of $56.34 and a 1 year high of $75.80. The firm has a market capitalization of $3.58 billion, a P/E ratio of 17.29, a PEG ratio of 2.01 and a beta of 0.48.

Prestige Consumer Healthcare (NYSE:PBH) last released its earnings results on Thursday, August 8th. The company reported $0.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.86 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The business had revenue of $267.10 million for the quarter, compared to the consensus estimate of $260.54 million. During the same quarter in the previous year, the business earned $1.06 earnings per share. Prestige Consumer Healthcare’s quarterly revenue was down 4.4% on a year-over-year basis. On average, equities analysts predict that Prestige Consumer Healthcare Inc. will post 4.43 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms recently commented on PBH. DA Davidson boosted their price objective on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Wednesday, August 28th. Jefferies Financial Group restated a “hold” rating and issued a $76.00 price target (up from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $94.20.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.